Segment Reporting (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Operating Costs and Expenses and Interest Expense, Net |
a)
Amortization expense of $342 related to the Pfizer Intangible asset has been excluded for the three months ended March 31, 2025 and included within depreciation and amortization.
b)
Share-based payment expense of $19 and $96 related to research and development and $42 and $42 related to general and administration have been excluded for the three months ended March 31, 2025 and 2024, respectively, and included within share-based compensation expense.
c)
Depreciation expense of $3 and $4 related to research and development and $4 and $3 related to general and administration have been excluded for the three months ended March 31, 2025 and 2024, respectively, and included within depreciation and amortization.
Interest Expense, Net
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Distribution of Long-Lived Assets by Geographical Area |
The distribution of long-lived assets by geographical area was as follows:
|